SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire & inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is trending strongly as its staking program sees significant adoption, with a substantial portion of tokens now locked, which the community views as a bullish indicator. Holders are rallying around its unique narrative as a 'pure belief asset' offering an alternative to traditional retirement plans, fueling widespread conviction.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending after securing FDA approval for NEREUS, marking the first new motion sickness treatment in decades. The community is highly focused on the drug's significant potential beyond motion sickness, particularly its ability to address nausea associated with GLP-1 weight loss medications, which could unlock a massive market. Investors are actively discussing whether the current valuation fully reflects this pivotal regulatory success and the company's broader pipeline.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology (AFJK) is currently experiencing extreme price swings and frequent trading halts, sparking active community discussion around its highly speculative nature as a "casino play." Many traders are focusing on its ultra-low float and high borrow rates, anticipating potential short squeezes, while others caution against a perceived "Chinese mafia pump" pattern often seen in similar volatile Chinese IPOs.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is generating significant buzz in the trading community, largely driven by its exceptionally low float and high insider ownership. Many view it as the next potential 'squeeze' play, drawing strong comparisons to recent low-float SPACs like AFJK and ASPC which saw substantial upward movement. This unique structural setup fuels active discussion about its potential for rapid price action.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is experiencing high volatility as investors await an overdue FDA decision on Relacorilant for Cushing's syndrome, a key PDUFA date that passed without official news. This has ignited intense community debate, with some highlighting strong GRACE trial data and the broader pipeline, while others express concern that the delay may indicate a Complete Response Letter amidst notable trading volume and market speculation.

A SPAC III Acquisition Corp. is a blank check company. The company was created for the purpose of effecting a merger, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on September 3, 2021 and is headquartered in Hong Kong.

A SPAC III Acquisition Corp. - Ordinary Shares - Class A

Alpha Capital Acquisition Co

Alpha Capital Acquisition Co. is generating significant buzz due to its extremely low public float and status as a SPAC, fueling speculation about a potential parabolic surge. The community is actively discussing its 'time bomb' setup and drawing comparisons to other volatile low-float stocks, with many anticipating a short squeeze amid frequent trading halts.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending amid analyst caution on its revenue outlook, largely attributed to crypto market weakness. Simultaneously, its holiday "free gift" giveaways are sparking considerable community debate, with users expressing both appreciation for small crypto rewards and frustration over app glitches. Conversations also revolve around its sensitivity to Bitcoin's price and its future as a broad fintech platform.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire (RDW) is trending following an eight-figure contract award to provide spacecraft docking systems for The Exploration Company's European Nyx capsule. This news, coupled with the company's significant short interest and its strategic position in the burgeoning space infrastructure and defense sectors, is fueling community speculation about a potential short squeeze and a substantial revaluation.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors eagerly await an FDA decision on its AXS-05 supplemental NDA for Alzheimer's disease agitation, viewed as a significant catalyst for an underserved market. This anticipation is fueled by consistently strong and growing prescription numbers for Auvelity in major depressive disorder, reflecting robust commercial execution. The company's expanding CNS pipeline and positive analyst sentiment continue to reinforce its perceived long-term value within the biopharmaceutical sector.

ProShares Trust - ProShares Short Bitcoin ETF

ProShares Short Bitcoin Strategy ETF

ProShares Short Bitcoin Strategy ETF ($BITI) is a focal point of market discussion as bearish sentiment on Bitcoin gains traction, with many anticipating a significant cryptocurrency pullback. The community is actively debating using inverse ETFs like BITI to either capitalize on or hedge against a potential Bitcoin correction, citing concerns over its speculative nature and "bubble" warnings from prominent investors. This reflects a prevailing view among some that Bitcoin's recent rally faces considerable downside risk.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Nio, Inc. fell over 2% on Friday, on course to mark the fourth consecutive session of losses.&nbsp;In Hong Kong and Singapore, Nio’s stock dropped nearly 4% earlier in the day, reflecting a broad negative sentiment.&nbsp;The company on Thursday hosted its 2024 year-end media event in Shanghai, but that appears to have failed to impress investors, contributing to the stock’s decline.According to Reuters, during the event, CEO William Li outlined Nio’s strategy to accelerate sales through better efficiency and cost control.&nbsp;He set a target of delivering 20,000 units of the Onvo L60 model by March next year. He also announced plans for the company’s third factory to begin production in the latter half of 2025.&nbsp;Despite these plans, Li acknowledged that the company’s growth of 30-40% over the past three years was unsatisfactory, which raised concerns.Deliveries of Nio’s main brand models have declined sequentially over the last two months, with Onvo growth not fully compensating for the dip in Nio branded vehicles, according to CNEVpost.&nbsp;Li reportedly denied that the Onvo brand was cannibalizing the main brand’s sales, attributing the decline to a reduction in promotions by at least RMB 10,000 ($1,380).In the third quarter, Nio missed both revenue and profit estimates due to weaker demand for its core brand, slower production ramp for Onvo, and rising operating costs.&nbsp;<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/NIO_sentiment_and_message_volume_Dec_13_0a8c02c5f8.png" alt="NIO sentiment and message volume Dec 13.png" width="1318" height="324"><figcaption>NIO sentiment and message volume Dec 13 as of 11:45 am ET | source: Stocktwits</figcaption></figure>Retail sentiment has turned more cautious on Stocktwits, to a ‘neutral’ score, as investors continue to digest the company’s struggles and uncertain growth trajectory.Optimists focused on Li’s commentary about delivery targets next year.<stembedurl>https://stocktwits.com/HonestJoe/message/596285856</stembedurl>Some bullish watchers even claimed that investing in the stock at current levels could boost returns tenfold by 2025.<stembedurl>https://stocktwits.com/sivkas/message/596338880</stembedurl>However, skeptics questioned the reliability of the CEO’s statements, arguing that the company has repeatedly failed to live up to promises in the past.<stembedurl>https://stocktwits.com/We__will__see/message/596374819</stembedurl><stembedurl>https://stocktwits.com/ForeverUSA/message/596380405</stembedurl>Shares of Chinese EV makers surged earlier this week after China’s Politburo <a href="https://stocktwits.com/news-articles/markets/5/xpev-nio-li-stocks-surge-after-china-vows-more-stimulus/cJaGDnfRi4">announced</a> plans for “more proactive fiscal policies and moderately loose monetary policies.”&nbsp;They also drew attention last week, reporting record November deliveries, with third-quarter guidance hinting at another record in December.Nio shares have lost more than 46% year-to-date, underscoring investor disappointment.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Li Bin, founder and CEO of NIO, attends the closing ceremony of 2024 China Auto Chongqing Summit on June 8, 2024 in Chongqing, China. (Photo by VCG/VCG via Getty Images)

Nio Stock Drops After Year-End Media Meet Fails To Impress: Retail Turns Cautious

CEO William Li reportedly acknowledged that the company’s growth of 30-40% over the past three years was unsatisfactory, which raised concerns.

Equity

CEO William Li reportedly acknowledged that the company’s growth of 30-40% over the past three years was unsatisfactory, which raised concerns.


JEMA
JPMorgan ActiveBuilders Emerging Markets Equity ETF

Feed

News

Sentiment

Fundamentals

Info

Latest JEMA News

JEMAJPMorgan ActiveBuilders Emerging Markets Equity ETF